Neb. Rev. Stat. § 38-2807.01

Current with changes from the 2024 legislative session enacted on or before 4/18/2024

Section 38-2807.01 - Bioequivalent, defined

Bioequivalent means drug products:

(1) That are legally marketed under regulations promulgated by the federal Food and Drug Administration;

(2) that are the same dosage form of the identical active ingredients in the identical amounts as the drug product prescribed;

(3) that comply with compendial standards and are consistent from lot to lot with respect to (a) purity of ingredients, (b) weight variation, (c) uniformity of content, and (d) stability; and

(4) for which the federal Food and Drug Administration has established bioequivalent standards or has determined that no bioequivalence problems exist.

Neb. Rev. Stat. § 38-2807.01

Laws 1977, LB 103, § 2; Laws 1983, LB 476, § 21; Laws 1989, LB 342, § 36; Laws 1996, LB 1044, § 720; Laws 1998, LB 1073, § 148; Laws 2001, LB 398, § 76; Laws 2003, LB 667, § 15; Laws 2005, LB 382, § 11; Laws 2007, LB296, § 622; Laws 2007, LB463, § 1232; R.S.1943, (2009), § 71-5402; Laws 2015, LB 37,§ 61; R.S.1943, (2016), § 38-28,110; Laws 2017, LB 481,§ 3.

Renumbered and amended by Laws 2017, LB 481,§ 3, eff. 1/1/2018, op. 1/1/2018.